Immunoregulation by lipids during the development of non-alcoholic steatohepatitis

被引:28
|
作者
Ramadori, Pierluigi [1 ]
Kroy, Daniela [1 ]
Streetz, Konrad L. [1 ]
机构
[1] RWTH Univ Hosp, Dept Internal Med 3, Pauwelsstr 30, D-52074 Aachen, Germany
关键词
Hepatocyte; free fatty acids (FFA); lipotoxicity; toll like receptors (TLRs); lymphocytes; FATTY LIVER-DISEASE; ENDOPLASMIC-RETICULUM STRESS; PROLIFERATOR-ACTIVATED RECEPTORS; NLRP3 INFLAMMASOME ACTIVATION; INDUCED INSULIN-RESISTANCE; ACID-INDUCED LIPOTOXICITY; HEPATIC STELLATE CELLS; NF-KAPPA-B; METABOLIC SYNDROME; FREE-CHOLESTEROL;
D O I
10.3978/j.issn.2304-3881.2015.01.02
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) represents the most common liver disorder in western countries and it is commonly associated with obesity and progression of the metabolic syndrome. Comprehending a wide spectrum of pathologic features, it is currently well recognized that a key point for the integrity of hepatocyte functionality in NAFLD is the progression from simple steatosis to non-alcoholic steatohepatitis (NASH). Indeed, activation of the innate immune system in response to hepatic metabolic stresses represents a central process that determines the evolution and the reversibility of liver damage. Despite of the burden of studies published in recent years, it is still intriguingly unclear how accumulation of lipids in hepatocytes triggers the activation of the inflammatory response leading to the recruitment of infiltrating cells of extra-hepatic origins. In this review we offer a general view on recent advances pointing out how different classes of lipids are able to specifically affect hepatocytes functionality and survival, thus differently influencing the organization of the hepatic immune response. On the other hand, we gathered recent studies intending to illustrate the basic mechanisms through which several non-parenchymal hepatic and extra-hepatic cell populations get activated in response to lipids. Finally, we indicate latter findings proposing how the immune system majorly contributes to the progression of NASH.
引用
收藏
页码:11 / 23
页数:13
相关论文
共 50 条
  • [1] Alcoholic and non-alcoholic steatohepatitis
    Neuman, Manuela G.
    French, Samuel W.
    French, Barbara A.
    Seitz, Helmut K.
    Cohen, Lawrence B.
    Mueller, Sebastian
    Osna, Natalia A.
    Kharbanda, Kusum K.
    Seth, Devanshi
    Bautista, Abraham
    Thompson, Kyle J.
    McKillop, Iain H.
    Kirpich, Irina A.
    McClain, Craig J.
    Bataller, Ramon
    Nanau, Radu M.
    Voiculescu, Mihai
    Opris, Mihai
    Shen, Hong
    Tillman, Brittany
    Li, Jun
    Liu, Hui
    Thomes, Paul G.
    Ganesan, Murali
    Malnick, Steve
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2014, 97 (03) : 492 - 510
  • [2] Alcoholic and non-alcoholic steatohepatitis
    不详
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2005, 201 (03) : 266 - 266
  • [3] Non-alcoholic steatohepatitis
    Saibara, T
    Onishi, S
    Ogawa, T
    Yoshida, S
    Enzan, H
    [J]. LANCET, 1999, 354 (9186): : 1299 - 1300
  • [4] Non-Alcoholic Steatohepatitis
    不详
    [J]. GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2008, 28 (20): : 61 - 61
  • [5] Non-alcoholic steatohepatitis
    Caballería, J
    Rodés, J
    [J]. MEDICINA CLINICA, 2003, 120 (17): : 670 - 675
  • [6] Non-alcoholic steatohepatitis
    Dancygier, H
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (33) : 930 - 930
  • [7] Non-alcoholic steatohepatitis
    Romero-Gomez, Manuel
    [J]. MEDICINA CLINICA, 2022, 159 (08): : 388 - 395
  • [8] Non-alcoholic steatohepatitis
    Petit, P
    Zarski, JP
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2000, 24 (02): : 157 - 159
  • [9] Non-alcoholic steatohepatitis
    Brierley, Rob
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (06): : 379 - 379
  • [10] Role of metabolic lipases and lipotoxicity in the development of non-alcoholic steatosis and non-alcoholic steatohepatitis
    Berlanga, Alba
    Guiu-Jurado, Esther
    Antonio Porras, Jose
    Aragones, Gemma
    Auguet, Teresa
    [J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2016, 28 (01): : 47 - 61